List With HCPCS Codes For Miscellaneous Services
The HCPCS codes for Miscellaneous Services (G0452-G0465) cover a range of procedures and services, including molecular pathology interpretation, continuous intraoperative neurophysiology monitoring, documentation of face-to-face visits for durable medical equipment determination, preparation with instillation of fecal microbiota, low dose rate prostate brachytherapy services, inpatient telehealth pharmacologic management, autologous platelet rich plasma for chronic wounds/ulcers, and hospital outpatient clinic visits.
1. HCPCS Code G0452
HCPCS G0452 describes the physician’s interpretation and report of molecular pathology procedures.
2. HCPCS Code G0453
HCPCS G0453 covers continuous intraoperative neurophysiology monitoring, performed remotely or nearby the operating room, for one patient for every 15 minutes.
3. HCPCS Code G0454
HCPCS G0454 pertains to the physician’s documentation of a face-to-face visit for durable medical equipment determination, conducted by a nurse practitioner, physician assistant, or clinical nurse specialist.
4. HCPCS Code G0455
HCPCS G0455 involves the preparation and instillation of fecal microbiota by any method, including the assessment of the donor specimen.
5. HCPCS Code G0458
HCPCS G0458 represents the composite rate for low dose rate (LDR) prostate brachytherapy services.
6. HCPCS Code G0459
HCPCS G0459 covers inpatient telehealth pharmacologic management, including prescription, use, and review of medication, with minimal medical psychotherapy.
7. HCPCS Code G0460
HCPCS G0460 involves the administration of autologous platelet rich plasma or other blood-derived products for non-diabetic chronic wounds/ulcers, including preparatory procedures, phlebotomy, centrifugation or mixing, and dressings, per treatment.
8. HCPCS Code G0463
HCPCS G0463 describes a hospital outpatient clinic visit for the assessment and management of a patient.
9. HCPCS Code G0465
HCPCS G0465 covers the administration of autologous platelet rich plasma (PRP) or other blood-derived products for diabetic chronic wounds/ulcers, using an FDA-cleared device for this indication, including preparatory procedures, administration, dressings, phlebotomy, centrifugation or mixing, per treatment.